The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco harm

The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers an easier way to identify nutrients linked to chronic diseases. The FDA announced its plans to push for a rule that would require food manufacturers to include a front-of-package nutrition label on most packaged food products.

The Trump administrations removed FDA's plan to ban menthol cigarettes. The Biden administration did not finalize the rule amid opposition.

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease.

Check your snacks before the Super Bowl. The Food and Drug Administration has given the highest risk classification to a recall for Lay’s potato chips. The FDA first announced the recall on Dec. 16 after Frito-Lay said a limited number of 13-ounce bags of Lay’s Classic Potato Chips may contain undeclared milk.

A voluntary recall was initiated by The W.S. Badger Company due to missing labels on a sunscreen product distributed nationwide.

Class I, according to the FDA, means exposure to or consumption of the product could cause "serious adverse health consequences or death."

On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.

The U.S. Food and Drug Administration ( FDA) has set its highest risk level—a Class I recall—over potential salmonella contamination in salad products.

For many, Lay’s potato chips are a go-to snack. Recently, a serious recall has raised concerns for consumers, especially those with food allergies.